Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system

References

• Akhilesh D, Anoop VN, Rao BP. (2011). Formulation and evaluation of gliclazide loaded maltodextrin based proniosomes. Int J Res Pharm Biomed Sci 2:1582–9
   Google Scholar
• Bernkop-Schnurch A, Guggi D, dan Pinter Y. (2004). Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J Control Release 94:177–86
   PubMed Web of Science ®Google Scholar
• Betageri GV, Parsons DL. (1992). Drug encapsulation and release from multilamellar and unilamellar liposomes. Int J Pharm 81:235–41
   Web of Science ®Google Scholar
• Carafa M, Santucci E, Alhaique F, et al. (1998). Preparation and properties of new unilamellar non-ionic/ionic surfactant vesicles. Int J Pharm 160:51–9
   Web of Science ®Google Scholar
• Corti G, Cirri M, Maestrelli F, et al. (2008). Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-b-cyclodextrin. Eur J Pharm Biopharm 68:303–9
   PubMed Web of Science ®Google Scholar
• Devalapally H, Chakilam A, Amiji MM. (2007). Role of nanotechnology in pharmaceutical product development. J Pharm Sci 96:2547–55
   PubMed Web of Science ®Google Scholar
• El-Mir MY, Nogueira V, Fontaine E, et al. (2000). Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 275:223–8
   PubMed Web of Science ®Google Scholar
• Essa EA. (2010). Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian J Pharm 4:227–33
   Google Scholar
• Fang J, Hong CT, Chiu W, Wang YY. (2001). Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 219:61–72
   PubMed Web of Science ®Google Scholar
• Finkelstein MC, Weissman G. (1979). Enzyme replacement via liposomes. Int J Pharm 588:202–16
   Google Scholar
• Guinedi AS, Mortada ND, Mansour S, Hathout RM. (2005). Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 306:71–82
   PubMed Web of Science ®Google Scholar
• Hao Y, Zhao F, Li N, et al. (2002). Studies on a high encapsulation of colchicine by niosome system. Int J Pharm 244:73–80
   PubMed Web of Science ®Google Scholar
• Hermann LS, Melander A. (1992). Biguanides: basic aspects and clinical use. In: Alberti KGMM, De Fronzo RA, Keen H, eds. International textbook of diabetes mellitus. New York: Wiley, 772–95
   Google Scholar
• Huang Y, Chen J, Chen X, et al. (2008). PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides. J Mater Sci: Mater Med 19:607–14
   PubMed Web of Science ®Google Scholar
• Junyapraset VB, Teeranachaideekul V, Supapem T. (2008). Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS PharmSci Tech 9:851–9
   PubMed Web of Science ®Google Scholar
• Karim KM, Mandal AS, Biswas N, et al. (2010). Niosome: a future of targeted drug delivery systems. J Advan Pharm Tech Res 1:374–80
   PubMedGoogle Scholar
• Khandare JN, Madhavi G, Tamhankar BM. (1994). Niosomes novel drug delivery system. East Pharm 37:61–4
   Google Scholar
• Ladbrooke BD, Williams RM, Chapman D. (1968). Studies on lecithin-cholesterol-water interaction by differential scanning calorimetry and X-ray diffraction. Biochim Biophys Acta 150:333–40
   PubMed Web of Science ®Google Scholar
• Lebacq EG, Tirzmalis A. (1972). Metformin and lactic acidosis. Lancet 1:314–15
   PubMed Web of Science ®Google Scholar
• Liu T, Guo R. (2007). Investigation of PEG 6000/Tween 80/Span 80/H2O niosome microstructure. Colloid Polym Sci 285:711–13
   Web of Science ®Google Scholar
• Manconi M, Valenti D, Loy G, Fadda LM. (2002). Niosomes as carriers for tretinoin. I. Preparation and properties. Int J Pharm 234:237–48
   PubMed Web of Science ®Google Scholar
• Murugan P, Pari L. (2007). Protective role of tetrahydrocurcumin on changes in the fatty acid composition in streptozotocin-nicotinamide induced type 2 diabetic rats. J Appl Biomed 5:31–8
   Google Scholar
• Namdeo A, Jain NK. (1999). Niosomal delivery of 5-flurouracil. J Micro Encapsul 16:731–40
   PubMed Web of Science ®Google Scholar
• Natali A, Ferrannini E. (2006). Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review. Diabetologia 49:434–41
   PubMed Web of Science ®Google Scholar
• Omaima NE, Ahmed HH. (1997). Formulation and evaluation of acetazolamide liposomes as an ocular drug delivery system. Int J Pharm 158:121–7
   Google Scholar
• Owen MR, Doran E, Halestrap AP. (2000). Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348:607–14
   PubMed Web of Science ®Google Scholar
• Papahadjopoulos D, Jacobson K, Nir S, Isac T. (1973). Phase transitions in phospholipid vesicles: fluorescence polarization and permeability properties concerning the effect of temperature and cholesterol. Biochim Biophys Acta 311:330–48
   PubMed Web of Science ®Google Scholar
• Pardakhty A, Varshosaz J, Rouholamini A. (2007). In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 328:130–41
   PubMed Web of Science ®Google Scholar
• Perrone J, Phillips C, Gaieski D. (2011). Occult metformin toxicity in three patients with profound lactic acidosis. J Emerg Med 40:271–5
   PubMed Web of Science ®Google Scholar
• Popli H, Nair MS. (1996). Niosomal delivery of tenoxicam. Indian J Pharm Sci 58:163–6
   Google Scholar
• Raja Naresh RA, Chandrashekhar G, Pillai GK, Udupa N. (1994). Anti-inflammatory activity of niosome encapsulated diclofenac sodium with Tween-85 in Arthitic rats. Indian J Pharmacol 26:46–8
   Google Scholar
• Sammour OA, Abu-Zaid SA, Abu-Selem ME, et al. (2004). Formulation and evaluation of timolol maleate-loaded niosomes as an ocular drug delivery system. Bull Fac Pham Cairo Univ 42:249–61
   Google Scholar
• Scheen AJ. (1996). Clinical pharmacokinetics of metformin. Clin Pharmacokinet 30:359–71
   PubMed Web of Science ®Google Scholar
• Srinivas S, Anand Kumar Y, Hemanth A, Anitha M. (2010). Preparation and evaluation of niosomes containing aceclofenac. Dig J Nanomater Biostruct 5:249–54
   Web of Science ®Google Scholar
• Trinder P. (1969). Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6:24–7
   Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. (1998). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–65
   PubMed Web of Science ®Google Scholar
• Van Hal DA, Bouwstra JA, Rensen AV, et al. (1996). Preparation and characterization of non-ionic surfactant vesicles. J Colloid Interface Sci 178:263–73
   Web of Science ®Google Scholar
• Vidon N, Chaussade S, Noel M, et al. (1988). Metformin in the digestive tract, diabetes. Res Clin Pract 4:223–9
   PubMed Web of Science ®Google Scholar
• Vyas SP, Mysore N, Jaitely V, Venkatesan N. (1998). Discoidal niosome based controlled ocular delivery of timolol maleate. Pharmazie 53:466–9
   PubMed Web of Science ®Google Scholar
• West JL, Halas NJ. (2000). Applications of nanotechnology to biotechnology commentary. Curr Opin Biotechnol 1:215–17
   Google Scholar
• Yoshioka T, Sternberg B, Florence AT. (1994). Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span-20, 40, 60 and 80) and sorbitan triester (Span 85). Int J Pharm 105:1–6
   Web of Science ®Google Scholar